image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Burford Capital - Shares break through £11

September 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BUR
  • Price:
  • 1128p
Shares in litigation funding specialist, Burford, raced to a new high above £11 fuelled by  interim results showing a terrific 151% increase in operating profit to US$155m, a full 63% above broker Liberum’s forecast. Litigation investment income grew 148% to US$161m, while record new commitments of US$488m were made.The shares had earlier spiked when two of its investments struck gold. The first consists of a claim alleging misappropriation of two airlines by the Argentine Government; costing Burford just US$13m it could be worth US$140m following a successful tribunal ruling. This is subject to appeal but is significant when compared to current year forecasts by Numis for almost US$147m pretax profit.Earlier, Burford crystal ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X